NCCN guidelines® insights: Small cell lung cancer, version 2.2018 featured updates to the NCCN guidelines

Gregory P. Kalemkerian, Billy W. Loo, Wallace Akerley, Albert Attia, Michael Bassetti, Yanis Boumber, Roy Decker, M. Chris Dobelbower, Afshin Dowlati, Robert J. Downey, Charles Florsheim, Apar Kishor P. Ganti, John C. Grecula, Matthew A. Gubens, Christine L. Hann, James A. Hayman, Rebecca Suk Heist, Marianna Koczywas, Robert E. Merritt, Nisha MohindraJulian Molina, Cesar A. Moran, Daniel Morgensztern, Saraswati Pokharel, David C. Portnoy, Deborah Rhodes, Chad Rusthoven, Rafael Santana-Davila, Charles C. Williams, Karin G. Hoffmann, Miranda Hughes

Research output: Contribution to journalArticlepeer-review

195 Scopus citations

Abstract

The NCCN Guidelines for Small Cell Lung Cancer (SCLC) address all aspects of disease management. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for SCLC regarding immunotherapy, systemic therapy, and radiation therapy. For the 2018 update, new sections were added on "Signs and Symptoms of SCLC" and "Principles of Pathologic Review."

Original languageEnglish
Pages (from-to)1171-1182
Number of pages12
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume16
Issue number10
DOIs
StatePublished - Oct 1 2018

Fingerprint

Dive into the research topics of 'NCCN guidelines® insights: Small cell lung cancer, version 2.2018 featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

Cite this